PHARMACODYNAMIC AND PHARMACOKINETIC COMPARISON OF 2 FORMULATIONS OF LORAZEPAM WITH PLACEBO

被引：0
|
作者：
ABRAMS, SML
HARRY, TVA
HEDGES, A
MURRAY, GR
TURNER, P
机构：
[1] ST BARTHOLOMEWS HOSP,DEPT CLIN PHARMACOL,LONDON EC1A 7BE,ENGLAND
[2] WYETH LABS,MAIDENHEAD SL6 0PH,BERKS,ENGLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 22卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P229 / P229
页数：1
相关论文
共 50 条
  • [1] A METHODOLOGICAL COMPARISON OF 2 FORMULATIONS OF TEMAZEPAM IN PHARMACOKINETIC AND PHARMACODYNAMIC ASPECTS
    TUOMAINEN, P
    PHARMACOLOGY & TOXICOLOGY, 1989, 64 (01): : 28 - 32
  • [2] ACUTE PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF 2 DIFFERENT FORMULATIONS OF TEMAZEPAM
    MATTILA, MJ
    MATTILA, M
    TUOMAINEN, P
    MEDICAL BIOLOGY, 1985, 63 (01): : 21 - 27
  • [3] Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide
    Clearie, Karine L.
    Williamson, Peter. A.
    Meldrum, Karen
    Gillen, Michael
    Carlsson, Lars-Goran
    Carlholm, Marie
    Ekelund, Jan
    Lipworth, Brian J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 504 - 513
  • [4] PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEEN VALPROATE AND LORAZEPAM
    SAMARA, E
    GRANNEMAN, R
    SAULIS, R
    WITT, G
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 153 - 153
  • [5] Pharmacokinetic and pharmacodynamic interaction of eszopiclone and lorazepam in healthy subjects.
    Niewoehner, J
    Anderson, AJ
    Maier, G
    PHARMACOTHERAPY, 2004, 24 (10): : 1421 - 1421
  • [6] Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
    Joshi, Ruthvika
    Kulkarni, Yogesh A.
    Wairkar, Sarika
    LIFE SCIENCES, 2018, 215 : 43 - 56
  • [7] PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF CONVENTIONAL AND CONTROLLED RELEASE FORMULATIONS OF MOTOPROLOL IN HEALTHY CHINESE SUBJECTS
    LEE, YT
    LIAU, CS
    WONG, ECK
    CHEN, WJ
    CHEN, MF
    CHEN, CC
    CARDIOVASCULAR DRUGS AND THERAPY, 1989, 3 (04) : 529 - 533
  • [8] Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects
    Saltzstein, Daniel
    Shore, Neal D.
    Moul, Judd W.
    Chu, Franklin
    Concepcion, Raoul
    de la Motte, Stephan
    McLane, John A.
    Atkinson, Stuart
    Yang, Alex
    Crawford, E. David
    THERAPEUTIC ADVANCES IN UROLOGY, 2018, 10 (02) : 43 - 50
  • [9] Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers
    Seokuee Kim
    Taegon Hong
    Jae-Wook Ko
    Wooseong Huh
    Jung-Ryul Kim
    BioDrugs, 2019, 33 : 101 - 112
  • [10] Comparison of the pharmacokinetic, pharmacodynamic, and safety profiles of three different formulations of intravenous epoprostenol sodium
    Nicolas, Laurent
    Gutierrez, Marcelo
    Dingemanse, Jasper
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345